MaxLinear, Inc. (NYSE: MXL), a provider of integrated, radio-frequency (RF) and mixed-signal semiconductor solutions for broadband communications applications, reported that it will present at the 11th Annual JMP Securities Research Conference on Monday, May 14, 2012, in San Francisco, CA. The presentation is scheduled at 10:00 AM PT.

MaxLinear, Inc. is a provider of integrated, radio-frequency (RF) and mixed-signal semiconductor solutions for broadband communications applications. MaxLinear is located in Carlsbad, California, and its address on the Internet is www.maxlinear.com.

****

ENGlobal Corp. (NASDAQ: ENG), a leading provider of energy-related project delivery solutions, reported that it has received approval from a senior lender with respect to a new $35 million senior revolving credit facility. The new credit facility will replace its existing senior credit facility, support liquidity needs, and fund working capital requirements.

The transaction, subject to documentation and customary closing conditions, is expected to close by the end of May.

ENGlobal is a provider of engineering and related project services principally to the energy sector throughout the United States and internationally. ENGlobal operates through three business segments: Engineering & Construction, Automation, and Field Solutions. The Engineering & Construction segment provides consulting services relating to the development, management and execution of projects requiring professional engineering as well as inspection, construction management, mechanical integrity, field support, quality assurance and plant asset management. ENGlobal's Automation segment provides services related to the design, fabrication and implementation of process distributed control and analyzer systems, advanced automation, information technology, cyber security and heat tracing projects. The Field Solutions segment provides project management and staffing for right-of-way and site acquisition, inspection, permitting, regulatory, and legislative outreach. ENGlobal has approximately 1,900 employees in 11 offices and 9 cities. Further information about the Company and its businesses is available at www.ENGlobal.com.

****

Crown Equity Holdings Inc. (CRWE.OB)

CRWE AD-Services, a division of Crown Equity Holdings Inc. (CRWE) is a full service multimedia advertising company specializing in internet marketing. Their goal is to provide you with a customized advertising blue print using their expansive resources.

CRWE Ad Services provides modern and unique advertising campaigns. They are dedicated to offering the most cost effective advertising solutions.

Among the best growth areas in advertising in recent years have been advertising on mobile devices, which is still in its infancy, advertising on movie screens and advertising online. Analysts at Gartner expect mobile advertising to reach $13 billion worldwide by 2013. Magna forecasts that global online advertising will grow to $71 billion in 2011.

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about CRWE AD-Services please visit http://crwe-adservices.com

For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com

****

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported that it has begun dosing ACH-3102 in a Phase 1 clinical trial.

ACH-3102 is Achillion's second generation pan-genotypic NS5A inhibitor being investigated for the treatment of chronic hepatitis C virus (HCV) infection.

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.

To view recent article please visit URL http://crweselect.com/29271/stock-alerts/ndaq-crwe-qcom-clwr-crweselectcom-stock-news-the-nasdaq-omx-group-crown-equity-holdings-qualcomm-incorporated-clearwire-corporation/

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the

move.

Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.